Taken together, we present a novel clinicopathological correlation such that expression of Notch pathway components and activated NOTCH1 levels predispose TSCC patients to lymph node metastasis, and that non-smokers TSCC patients tend to have higher NOTCH1 levels as compared to smokers. Here, NOTCH1 is linked to metastatic malignant neoplasm in the lymph nodes.